BIOMAT Database Logo BIOMAT Database Logo

[Solubility and dissolution rate of meprobamate: significant cases (author's transl)]. 1979

M Draguet-Brughmans, and M Azibi, and R Bouché

UI MeSH Term Description Entries
D008620 Meprobamate A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603) Dapaz,Equanil,Meprospan,Miltown,Méprobamate Richard,Tranmep,Visano
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

M Draguet-Brughmans, and M Azibi, and R Bouché
[Studies on the dissolution test of drugs. I. Disintegration and dissolution of meprobamate tablets (author's transl)].
January 1975, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences,
M Draguet-Brughmans, and M Azibi, and R Bouché
[Technological methods for improving the solubility and increasing the dissolution rate of slightly soluble drugs (author's transl)].
January 1982, Die Pharmazie,
M Draguet-Brughmans, and M Azibi, and R Bouché
[The dissolution rate and absorption of nithiocyamine solid dispersion (author's transl)].
January 1979, Yao xue xue bao = Acta pharmaceutica Sinica,
M Draguet-Brughmans, and M Azibi, and R Bouché
Theoretical Analysis of Drug Dissolution: I. Solubility and Intrinsic Dissolution Rate.
September 2016, Journal of pharmaceutical sciences,
M Draguet-Brughmans, and M Azibi, and R Bouché
Solubility and dissolution rate studies of ergotamine tartrate.
July 1980, Journal of pharmaceutical sciences,
M Draguet-Brughmans, and M Azibi, and R Bouché
[Solubility and rate of dissolution in lipoid vehicles].
March 1988, Die Pharmazie,
M Draguet-Brughmans, and M Azibi, and R Bouché
Solubility and intrinsic dissolution rate of alprazolam crystal modifications.
December 1996, Pharmaceutical development and technology,
M Draguet-Brughmans, and M Azibi, and R Bouché
Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
October 2006, Drug development and industrial pharmacy,
M Draguet-Brughmans, and M Azibi, and R Bouché
Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
October 2010, Molecular pharmaceutics,
M Draguet-Brughmans, and M Azibi, and R Bouché
[Influence of viscosity of the solvent on the dissolution rate (author's transl)].
April 1976, Archiv der Pharmazie,
Copied contents to your clipboard!